Skip to main content
Clinical Trials/CTRI/2020/09/027525
CTRI/2020/09/027525
Not yet recruiting
Phase 1

To study the potential role of Platelet Rich Plasma as a therapeutic modality in Melasma

Dr RPG Medical College Kangra0 sites0 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue
Sponsor
Dr RPG Medical College Kangra
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr RPG Medical College Kangra

Eligibility Criteria

Inclusion Criteria

  • Age \> 18 years
  • Non Pregnant and Non lactating women
  • Patients not taking oral contraceptives.
  • Patients with no history of chronic liver disease, thromboembolism, bleeding disorders, and abnormal coagulation profile; on antiplatelet, anticoagulant or systemic chemotherapy.
  • Patients with no history of hypertrophic scars or keloids, recurrent herpes infection or current cutaneous infection
  • Patients with no history psychological disorders
  • Patients who have not taken any other melasma therapy within last 3 months.

Exclusion Criteria

  • Age less than 18 years
  • Pregnant and lactating women
  • Patients taking oral contraceptives
  • Patients with history of chronic liver disease, thromboembolism, bleeding disorders, and abnormal coagulation profile; on antiplatelet, anticoagulant or systemic chemotherapy
  • Patients with history of hypertrophic scars or keloids, recurrent herpes infection or current cutaneous infection
  • Patients with psychological disorders
  • Patients having unrealistic expectation from the treatment
  • Patients who have taken any other melasma therapy within last 3 months

Outcomes

Primary Outcomes

Not specified

Similar Trials